<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01722448</url>
  </required_header>
  <id_info>
    <org_study_id>12-0504</org_study_id>
    <nct_id>NCT01722448</nct_id>
  </id_info>
  <brief_title>Nutritional Prevention of Exertional Muscle Dysfunction</brief_title>
  <acronym>MUSREC</acronym>
  <official_title>Nutritional Prevention of Exertional Muscle Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators want to find out whether a choline supplement can protect muscle health in&#xD;
      young men with very common genetic vulnerabilities. Men, who respond to a brief, but intense&#xD;
      set of arm exercise and have a common genetic profile, will be asked to use a choline&#xD;
      supplement for three weeks and a placebo for three weeks. Before the begin of the&#xD;
      supplementation study and after 3 and 6 weeks the investigators will test response to the&#xD;
      exercise challenge and ask that all consumed foods are recorded.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An initial screening questionnaire will determine general eligibility. The investigators will&#xD;
      screen white young males with low to moderate choline intake (&lt;450 mg/d) for CK response to&#xD;
      exercise (high/low) by having them do intense eccentric exercise (12 elbow flexor&#xD;
      contractions of non-dominant arm with dumbbell at 100% maximal lift capacity) and then 72&#xD;
      hours (3 days) later draw 250 Î¼l capillary blood by finger stick for CK, metabolomic and&#xD;
      genetic measurements.&#xD;
&#xD;
      The investigators plan to recruit 30 CK responders with an 1958 A allele of the&#xD;
      methylenetetrahydrofolate dehydrogenase 1 (MTHFD1), which is present in about 60% of&#xD;
      Caucasian males.&#xD;
&#xD;
      All participants will be asked to complete on three days 24-hour diet interviews with an&#xD;
      online automated program provided by the National Cancer Institute. Participants of the&#xD;
      intervention study will also have to be complete interviews on the final three days of the&#xD;
      two intervention periods The recruited candidates will do an initial exercise challenge with&#xD;
      no intervention, then a second challenge after three weeks with the first supplement&#xD;
      (randomized choline or placebo), then a third challenge after another three weeks with the&#xD;
      complementary second supplement (choline if they had placebo first, placebo if they had&#xD;
      choline first).&#xD;
&#xD;
      Samples identified only by code will be stored indefinitely at the UNC Nutrition Research&#xD;
      Institute to permit the analysis of additional genetic markers related to muscle health and&#xD;
      choline metabolism when the capacity for the analysis of such markers becomes available. Such&#xD;
      analyses may be carried out at the University of North Carolina Nutrition Research Institute&#xD;
      (UNC NRI) or at external laboratories providing the service for the PI. Samples will be&#xD;
      destroyed once no such additional analyses are intended or feasible anymore or if the&#xD;
      investigators do not continue this research. Storage of the samples is not optional.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Creatine Kinase (CK) activity</measure>
    <time_frame>3 weeks</time_frame>
    <description>CK activity in response to an exertional challenge will be measured.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Muscle Dysfunction</condition>
  <condition>Exertional Rhabdomyolysis</condition>
  <condition>Muscle Strength</condition>
  <arm_group>
    <arm_group_label>Choline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Phosphatidyl choline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Vegetable oil</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Choline</intervention_name>
    <description>4 capsules with 480 mg choline per day</description>
    <arm_group_label>Choline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Caucasian&#xD;
&#xD;
          -  choline intake less than 450 mg&#xD;
&#xD;
          -  exertional muscle dysfunction&#xD;
&#xD;
          -  susceptible genetic profile&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  severe chronic illness&#xD;
&#xD;
          -  limited range of arm motion&#xD;
&#xD;
          -  required use of prescription medication&#xD;
&#xD;
          -  required use of dietary supplements&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Kohlmeier, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UNC Nutrition Research Institute</name>
      <address>
        <city>Kannapolis</city>
        <state>North Carolina</state>
        <zip>28081</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>November 2, 2012</study_first_submitted>
  <study_first_submitted_qc>November 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 6, 2012</study_first_posted>
  <last_update_submitted>October 12, 2017</last_update_submitted>
  <last_update_submitted_qc>October 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>muscle</keyword>
  <keyword>muscle dysfunction</keyword>
  <keyword>choline</keyword>
  <keyword>exercise</keyword>
  <keyword>exertional rhabdomyolysis</keyword>
  <keyword>rhabdomyolysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhabdomyolysis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Choline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

